|
End-of-day quote
Shanghai S.E.
18/11/2026
|
5-day change | 1st Jan Change | ||
| 7.420 CNY | -1.46% |
|
-6.67% | -23.51% |
| 16/10 | Sinotherapeutics Inc. Reports Earnings Results for the Nine Months Ended September 30, 2026 | CI |
| 27/08 | Sinotherapeutics Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 3.33B 500M 454M 419M 378M 714M 46.68B 741M 5.05B 2B 25.19B 1.87B 1.83B 79.58B | P/E 2024 |
35.9x | P/E 2025 | 88.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.59B 388M 352M 325M 293M 554M 36.22B 575M 3.92B 1.55B 19.55B 1.45B 1.42B 61.75B | EV / Sales 2024 |
7.4x | EV / Sales 2025 | 8.08x |
| Free-Float |
25.56% | Yield 2024 |
0.62% | Yield 2025 | 0.36% |
| 1 day | -1.46% | ||
| 1 week | -6.67% | ||
| Current month | -5.60% | ||
| 1 month | -15.97% | ||
| 3 months | -30.39% | ||
| 6 months | -19.26% | ||
| Current year | -23.51% |
| 1 week | 7.33 | 8.77 | |
| 1 month | 7.33 | 9.05 | |
| Current year | 7.02 | 11.33 | |
| 1 year | 7.02 | 11.33 | |
| 3 years | 6.3 | 14 | |
| 5 years | 6.3 | 28 | |
| 10 years | 6.3 | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Jie Guo
CEO | Chief Executive Officer | 53 | 06/04/2023 |
Yi Ming Wu
DFI | Director of Finance/CFO | 57 | 30/04/2025 |
Hui Zhang
IRC | Investor Relations Contact | 44 | 31/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jun Ye
CHM | Chairman | 53 | 18/08/2020 |
Xiao Ming Ying
BRD | Director/Board Member | 58 | 01/08/2012 |
Si Yu Shen
BRD | Director/Board Member | 44 | 01/09/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.46% | -6.67% | -33.09% | -37.70% | 507M | ||
| -1.70% | -3.35% | +34.87% | +132.46% | 1,261B | ||
| -0.67% | -1.48% | +38.13% | +84.29% | 671B | ||
| -1.50% | -1.95% | +23.67% | +109.12% | 518B | ||
| -0.69% | +0.37% | +31.53% | +70.10% | 387B | ||
| -2.67% | -5.05% | +44.92% | +36.10% | 353B | ||
| -1.35% | -0.95% | +28.90% | +56.00% | 300B | ||
| -1.13% | -1.80% | +0.59% | +35.03% | 283B | ||
| -2.16% | -4.17% | +30.40% | +69.05% | 248B | ||
| -0.22% | +0.19% | +33.71% | +123.76% | 211B | ||
| Average | -1.38% | -1.30% | +23.36% | +67.82% | 423B | |
| Weighted average by Cap. | -1.41% | -0.55% | +31.51% | +92.12% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 512M 76.72M 69.65M 64.34M 58.04M 110M 7.17B 114M 775M 307M 3.87B 288M 282M 12.22B | 447M 66.97M 60.79M 56.16M 50.66M 95.64M 6.26B 99.31M 677M 268M 3.38B 251M 246M 10.67B |
| Net income | 128M 19.15M 17.38M 16.06M 14.49M 27.35M 1.79B 28.4M 194M 76.54M 965M 71.85M 70.34M 3.05B | 47.48M 7.12M 6.46M 5.97M 5.39M 10.17M 665M 10.56M 71.95M 28.46M 359M 26.72M 26.15M 1.13B |
| Net Debt | -734M -110M -99.86M -92.24M -83.22M -157M -10.28B -163M -1.11B -440M -5.55B -413M -404M -17.52B | -746M -112M -102M -93.87M -84.68M -160M -10.46B -166M -1.13B -447M -5.64B -420M -411M -17.83B |
Employees
319
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/11/26 | CNY 7.420 | -1.46% | 4,006,799 |
| 17/11/26 | CNY 7.530 | -2.84% | 5,020,162 |
| 16/11/26 | CNY 7.750 | -2.52% | 5,775,131 |
| 13/11/26 | CNY 7.950 | -3.28% | 8,176,937 |
| 12/11/26 | CNY 8.220 | +1.86% | 12,083,594 |
- Stock Market
- Stocks
- 688247 Stock
Select your edition
All financial news and data tailored to specific country editions
















